Support Services Increased Genetic Testing for Cancer Relatives
Personalized navigation assistance helped more family members of cancer patients complete crucial genetic testing.
Updated on Oct. 9, 2026 in Cancer
Live Poll
If a family history of cancer existed, would you complete recommended genetic testing?
A new study found that providing personalized support significantly improved genetic testing rates among first-degree relatives of patients with BRCA1/2 variants. This intervention could offer a more effective approach for families managing inherited cancer risks.
Why it matters
Informing family members of their inherited cancer risk is often not enough to ensure they pursue testing, creating a barrier to early prevention. This study highlights how targeted support can bridge that gap and improve health outcomes for high-risk relatives.
In a randomized trial of 151 probands with newly diagnosed BRCA1/2 variants, researchers found that navigation support significantly increased testing uptake among relatives. By the 18-month mark, 90 percent of those in the supported group had completed genetic testing.
The players
Journal of Clinical Oncology
A peer-reviewed medical journal that publishes original research on cancer treatment and prevention.
MD Anderson Cancer Center
A Houston-based institution globally recognized for its cancer care, research, and educational programs.
The details
The study utilized a facilitated cascade testing model where navigation support assisted relatives through the complex logistics of the testing process. This approach is designed to overcome common barriers that prevent family members from acting on familial risk information. Among the 206 total relatives who underwent testing, 46 percent were found to carry a pathogenic or likely pathogenic variant, with 86 percent of those carrying the specific familial variant identified in the patient.
Timeline
September 29, 2026: Study findings published in the Journal of Clinical Oncology.
6 months: Testing uptake was measured between the study groups.
18 months: Testing completion was achieved for 90 percent of the intervention group.
Health Landscape
This development marks a shift from relying on passive communication to active, facilitated support in the management of hereditary cancer risk. It aligns with the NCI Cancer Moonshot initiative by targeting specific strategies to improve the reach of precision medicine for at-risk families.
If you or a family member has been diagnosed with a BRCA1/2 variant, it is worth discussing the availability of genetic counseling and testing support services with your physician. These resources can help navigate the testing process for family members and ensure they receive necessary information.
The takeaway
Facilitated navigation can overcome the common barriers that prevent relatives of cancer patients from pursuing genetic testing. Families should talk with their healthcare team about specific support programs available to ensure all high-risk relatives are informed and tested.
Further reading
For more on the latest research and screening developments, visit Cancer.
Source note: This article includes information reported by Healthday.
Live Poll
If a family history of cancer existed, would you complete recommended genetic testing?
